Načítá se...
A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer
Elevated expression of the chemokine receptor CCR4 in tumors is associated with poor prognosis in several cancers. Here, we have determined that CCR4 was highly expressed in human renal cell carcinoma (RCC) biopsies and observed abnormal levels of CCR4 ligands in RCC patient plasma. An antagonistic...
Uloženo v:
Vydáno v: | J Clin Invest |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
American Society for Clinical Investigation
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5330727/ https://ncbi.nlm.nih.gov/pubmed/28134623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI82976 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|